Evaluation of regulatory immune cells in a new therapy for malignant melanoma
Evaluation of regulatory immune cells in a new therapy for malignant melanoma
批准号:
23791264
负责人:
TANIOKA Miki
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
与血液学系合作,使用识别人黑素瘤细胞系的树突状细胞对IV期黑素瘤患者进行新型免疫疗法的临床试验。当地伦理委员会批准了这项研究。本研究揭示了调节性T细胞的一部分。
英文摘要
A clinical trial of a novel immunotherapy for stage IV melanoma patients using dendritic cells recognizing a human melanoma cell line was conducted in corporation with the department of hematology. A local ethics committee approved this study. This study revealed a part of regulatory T cell in this study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1159/000345559
发表时间:
2012-09
期刊:
Case reports in dermatology
影响因子:
0.9
作者:
[Iga N, Endo Y, Fujisawa A, Matsumura Y, Kabashima K, Tanioka M, Miyachi Y]
通讯作者:
Miyachi Y
Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
索拉非尼单次疗法成功治疗头皮血管肉瘤。
DOI:
10.1001/archdermatol.2011.2819
发表时间:
2012
期刊:
Arch Dermatol.
影响因子:
--
作者:
[Kaku Y, Tanioka M, Tanizaki H, Miyachi Y, Iga N, Ono S]
通讯作者:
Ono S
Popliteal sentinel lymph node biopsy is important in malignant melanoma of the distal lower extremities: a case report of acral lentigenous melanoma with simultaneous inguinal and popliteal lymph node micrometastases.
腘前哨淋巴结活检对于远端下肢恶性黑色素瘤很重要:肢端雀斑黑色素瘤同时发生腹股沟和腘淋巴结微转移的病例报告。
DOI:
--
发表时间:
2012
期刊:
Eur J Dermatol
影响因子:
2.5
作者:
[Kaku Y, Tanioka M, Tanizaki H, Miyachi Y]
通讯作者:
Miyachi Y
Research on the anti-tumor immunity against human malignant melanoma transplanted in a immune-deficient mice.
-
批准号:20790797
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:TANIOKA Miki
-
依托单位:
海外基金